Posts Tagged ‘metastatic disease’

Nivolumab in Renal-Cell Carcinoma

Posted by • November 6th, 2015

In a randomized trial involving patients with advanced previously treated renal-cell carcinoma, nivolumab produced higher response rates than everolimus (25% vs. 5%) and median overall survival was longer (by 5.4 months), to more than 2 years. A new Original Article summarizes. Each year, an estimated 338,000 new cases of renal-cell carcinoma are diagnosed worldwide, and approximately 30%… Read More…

Circulating Tumor DNA

Posted by • March 27th, 2013

Fifty years ago, oncologists relied upon the clinical exam to follow breast cancer patients with metastatic disease. Patients were treated with chemotherapy, and then the physicians waited for symptoms to return before deciding on the next treatment course. Some patients could go months or even years without symptoms, but during this time they played a… Read More…

Androgen Deprivation for Prostate Cancer

Posted by • July 15th, 2011

In a new study by Jones et al., Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer, a course of androgen-deprivation therapy before and during radiotherapy prolonged 10-year survival by about 7% among men with intermediate-risk prostate cancer. The risk of erectile dysfunction with the addition of hormone therapy was also about 7% higher. In the… Read More…